1. Home
  2. IQV vs EL Comparison

IQV vs EL Comparison

Compare IQV & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$168.96

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Logo Estee Lauder Companies Inc. (The)

EL

Estee Lauder Companies Inc. (The)

HOLD

Current Price

$73.09

Market Cap

26.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQV
EL
Founded
1982
1946
Country
United States
United States
Employees
93000
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.6B
26.4B
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
IQV
EL
Price
$168.96
$73.09
Analyst Decision
Strong Buy
Buy
Analyst Count
16
21
Target Price
$227.13
$99.62
AVG Volume (30 Days)
1.2M
5.4M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
1.96%
EPS Growth
4.67
N/A
EPS
7.84
0.57
Revenue
$9,739,000,000.00
$14,326,000,000.00
Revenue This Year
$6.78
$7.59
Revenue Next Year
$5.88
$4.18
P/E Ratio
$22.03
$125.32
Revenue Growth
41.60
N/A
52 Week Low
$134.65
$50.61
52 Week High
$247.05
$121.64

Technical Indicators

Market Signals
Indicator
IQV
EL
Relative Strength Index (RSI) 44.69 37.64
Support Level $159.42 N/A
Resistance Level $170.89 $93.17
Average True Range (ATR) 6.19 4.06
MACD 1.31 0.77
Stochastic Oscillator 36.04 27.80

Price Performance

Historical Comparison
IQV
EL

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

About EL Estee Lauder Companies Inc. (The)

Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Share on Social Networks: